Related Experiment Videos
The hypercoagulability of polycythemia vera
1Brown University.
Hospital Practice (Office Ed.)
|September 30, 1993
Abstract:
Thrombosis is the most common cause of death in patients with this myeloproliferative syndrome. Phlebotomy, hydroxyurea, and antiplatelet agents are the mainstays of therapy but may not stave off a lethal embolism.